| Name | FAM83A antisense RNA 1 |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n FAM83A‐AS1 is an oncogenic long noncoding RNA that contributes to tumor progression in multiple cancer types—including lung adenocarcinoma, non‐small cell lung cancer, hepatocellular carcinoma, and esophageal cancer—through dual mechanisms. On one hand, FAM83A‐AS1 functions as a competing endogenous RNA by “sponging” specific microRNAs such as"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "(miR‑150‑5p)"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": "(miR‑141‑3p), and"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": "(miR‑495‑3p). This sequestration relieves repression on target oncogenes such as matrix metalloproteinase 14 (MMP14) and FAM83A itself, thereby promoting cell proliferation, migration, invasion, and epithelial–mesenchymal transition (EMT)."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "3"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n On the other hand, FAM83A‐AS1 enhances the stability of FAM83A mRNA through direct post‐transcriptional mechanisms. In hepatocellular carcinoma, for example, FAM83A‐AS1 binds to the RNA‐binding protein NOP58 to increase FAM83A mRNA stability"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": ", while in non‐small cell lung cancer it forms an RNA duplex and interacts with FBL to similarly stabilize FAM83A pre‐mRNA, resulting in activation of downstream ERK signaling pathways."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n In esophageal cancer, upregulation of FAM83A‐AS1 is associated with enhanced migratory potential through its negative regulation of miR‑495‑3p."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": " Across multiple studies, the overexpression of FAM83A‐AS1 has also been incorporated into prognostic lncRNA signatures that correlate with poor overall survival and advanced clinical stage in lung cancers and other malignancies."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "7", "end_ref": "13"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Collectively, these findings indicate that FAM83A‐AS1 serves as a critical regulator of oncogene expression—both by acting as a decoy for tumor‐suppressive microRNAs and by stabilizing FAM83A mRNA—thereby driving aggressive tumor behaviors and offering a promising target for therapeutic intervention.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Guodong Xiao, Peili Wang, Xiaoqiang Zheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "FAM83A-AS1 promotes lung adenocarcinoma cell migration and invasion by targeting miR-150-5p and modifying MMP14."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Cycle (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/15384101.2019.1664225"}], "href": "https://doi.org/10.1080/15384101.2019.1664225"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31522616"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31522616"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Hongyu Huang, Chuyi Yang, Qichen Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA FAM83A antisense RNA 1 (lncRNA FAM83A-AS1) targets microRNA-141-3p to regulate lung adenocarcinoma cell proliferation, migration, invasion, and epithelial-mesenchymal transition progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Bioengineered (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/21655979.2022.2037871"}], "href": "https://doi.org/10.1080/21655979.2022.2037871"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35164653"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35164653"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Gaoming Wang, Xiaokun Li, Yu Yao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "FAM83A and FAM83A-AS1 both play oncogenic roles in lung adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Lett (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ol.2021.12558"}], "href": "https://doi.org/10.3892/ol.2021.12558"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33732373"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33732373"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Jinyu He, Jiao Yu "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA FAM83A-AS1 facilitates hepatocellular carcinoma progression by binding with NOP58 to enhance the mRNA stability of FAM83A."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biosci Rep (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BSR20192550"}], "href": "https://doi.org/10.1042/BSR20192550"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31696213"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31696213"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Wenyi Wang, Zhunlin Zhao, Chun Xu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA FAM83A-AS1 promotes lung adenocarcinoma progression by enhancing the pre-mRNA stability of FAM83A."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Thorac Cancer (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/1759-7714.13928"}], "href": "https://doi.org/10.1111/1759-7714.13928"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33687144"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33687144"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "G-M Huang, H-L Zang, Y-X Geng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA FAM83A-AS1 aggravates the malignant development of esophageal cancer by binding to miR-495-3p."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_202009_23024"}], "href": "https://doi.org/10.26355/eurrev_202009_23024"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33015782"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33015782"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Xiaoting Zhang, Yue Su, Xian Fu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Evaluation of the Prognostic Value of Long Noncoding RNAs in Lung Squamous Cell Carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Oncol (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2022/9273628"}], "href": "https://doi.org/10.1155/2022/9273628"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35069738"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35069738"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Jianbin You, Wenting Fang, Qiurong Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of a RNA-Seq Based Prognostic Signature with Seven Immune-Related lncRNAs for Lung Adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Lab (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7754/Clin.Lab.2020.200663"}], "href": "https://doi.org/10.7754/Clin.Lab.2020.200663"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33739047"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33739047"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Yong Yu, Kaiming Ren "}, {"type": "b", "children": [{"type": "t", "text": "Five long non-coding RNAs establish a prognostic nomogram and construct a competing endogenous RNA network in the progression of non-small cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cancer (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12885-021-08207-7"}], "href": "https://doi.org/10.1186/s12885-021-08207-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33892664"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33892664"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Liwei Wu, Zilu Wen, Yanzheng Song, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A novel autophagy-related lncRNA survival model for lung adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Mol Med (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jcmm.16582"}], "href": "https://doi.org/10.1111/jcmm.16582"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33987935"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33987935"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Yugang Guo, Zhongyu Qu, Dandan Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of a prognostic ferroptosis-related lncRNA signature in the tumor microenvironment of lung adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Discov (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41420-021-00576-z"}], "href": "https://doi.org/10.1038/s41420-021-00576-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34312372"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34312372"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Zetian Gong, Qifan Li, Jun Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A novel signature based on autophagy-related lncRNA for prognostic prediction and candidate drugs for lung adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Transl Cancer Res (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.21037/tcr-21-1554"}], "href": "https://doi.org/10.21037/tcr-21-1554"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35261881"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35261881"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Xiaojun Yao, Hongwei Zhang, Shujun Tang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Bioinformatics Analysis to Reveal Potential Differentially Expressed Long Non-Coding RNAs and Genes Associated with Tumour Metastasis in Lung Adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Onco Targets Ther (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2147/OTT.S242745"}], "href": "https://doi.org/10.2147/OTT.S242745"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32368079"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32368079"}]}]}]}
|
| Synonyms | HCCC11_V2, HCCC11_V1, HCCC11 |
| NCBI Gene ID | 100131726 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
FAM83A-AS1 has 260 functional associations with biological entities spanning 2 categories (cell line, cell type or tissue, gene, protein or microRNA) extracted from 6 datasets.
Click the + buttons to view associations for FAM83A-AS1 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of FAM83A-AS1 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of FAM83A-AS1 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of FAM83A-AS1 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of FAM83A-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of FAM83A-AS1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of FAM83A-AS1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |